More precisely, similar to cancer cells, dendritic cells can suppress an immune response by expressing surface molecules, such as programmed cell death ligand 1 (PDL-1), that inhibit T-cells by binding to their membranous receptor programmed cell-death protein 1 (PD-1). This evidence concerns the gene PDCD1 and cancer.